Thousands of investors in Keydata plans backed by Lifemark are facing another setback in their bid for compensation after the administrator says he is "really questioning" the quality of traded life policies (TLP).
The FSCS has said the final level of compensation to investors will depend on the value still left in beleaguered Lifemark. However, KPMG's Eric Collard, who has spent a year working on re-financing deals to keep Lifemark from liquidation, says the TLP industry is "too young" to accurately assess mortality dates, and therefore the final value of the 303 Lifemark policies. Lifemark has had about 88% fewer maturities this year than the projections estimated when policies were purchased for the portfolio. The fund is struggling to pay $4.5m (£2.8m) a month for the premiums on the TL...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes